
    
      This is a 36 month multi-center, open label, unblinded and blinded study on subjects have had
      a heart transplant within the previous 12 months and are scheduled to undergo an
      endomyocardial biopsy. The breath test will be performed to identify and validate the
      predicative algorithms that identify breath biomarkers for heart transplant rejection.
    
  